DANIEL MICHAEL FECKOURY

Allopathic & Osteopathic Physicians|Family Medicine CARROLLTON, GA NPI 1659516367

General Payments — all program years on this page

$981.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 56
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $272.08 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $272.0815

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $94.785
Lilly USA, LLC $52.723
Acerta Pharma LLC $34.962
ViiV Healthcare Company $34.272
PFIZER INC. $24.911
Astellas Pharma US Inc $17.361
Merck Sharp & Dohme Corporation $13.081

By program year

Program yearAmountRecords
2018 $29.912
2019 $100.796
2020 $84.936
2021 $131.598
2022 $50.913
2023 $311.7816
2024 $272.0815

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096611144 Novo Nordisk Inc $15.99 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096982696 Novo Nordisk Inc $19.07 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097067663 Novo Nordisk Inc $19.53 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097298603 Novo Nordisk Inc $22.57 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097556623 Novo Nordisk Inc $17.62 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105499344 AstraZeneca Pharmaceuticals LP $15.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105607537 AstraZeneca Pharmaceuticals LP $19.96 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112738713 ViiV Healthcare Company $13.39 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112800030 ViiV Healthcare Company $20.88 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131536699 PFIZER INC. $24.91 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136118457 Lilly USA, LLC $17.27 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136121078 Lilly USA, LLC $19.45 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136142539 Lilly USA, LLC $16.00 03/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139389358 Astellas Pharma US Inc $17.36 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141671651 Merck Sharp & Dohme LLC $13.08 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.